Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Moises M. Gallardo-Pérez"'
Autor:
Max Robles-Nasta, Daniela Sánchez-Bonilla, Moises M. Gallardo-Pérez, Edgar J. Hernández-Flores, Merittzel A. Montes-Robles, María de L. Pastelín-Martínez, Juan C. Olivares-Gazca, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles
Publikováno v:
Revista de Investigación Clínica, Vol 76, Iss 2 (2024)
Background: Chronic myelogenous leukemia is a neoplastic proliferation of the granulocytic series. In Mexico, chronic myelogenous leukemia accounts for approximately 10% of all leukemias. Tyrosine-kinase inhibitors are considered front-line therapy i
Externí odkaz:
https://doaj.org/article/8a1fc4cbe7734a1eb3630b5eae574bf0
Autor:
Miranda Melgar-de-la-Paz, Moises M. Gallardo-Pérez, Juan C. Olivares-Gazca, Guillermo J. Ruiz-Argüelles
Publikováno v:
Revista de Investigación Clínica, Vol 76, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/350a2ae11dc04515a5062b2bcfcf2172
Autor:
Moisés M. Gallardo-Pérez, Robert Peter Gale, Oscar A. Reyes-Cisneros, Daniela Sánchez-Bonilla, José A. Fernández-Gutiérrez, Wendy Stock, Iván Murrieta-Álvarez, Juan Carlos Olivares-Gazca, Guillermo J. Ruiz-Delgado, Rafael Fonseca, Guillermo J. Ruiz-Argüelles
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
The therapy of children with acute lymphoblastic leukemia (ALL) in limited resource geospaces is challenging and must balance safety, efficacy, availability, and affordability. We modified the control arm of the St. Jude Total XI protocol for outpati
Externí odkaz:
https://doaj.org/article/53721ee80d1d4a498117dfc902764eae